Triple-negative breast cancer (TNBC) is a special subtype of breast cancer, accounting for
10–20% of breast cancers with high intrinsic heterogeneity. Its unique immune …

Tumor immunotherapy is praised as “green therapy,” which can attack tumor by mobilizing
immune system. By removing the inhibition of immune cells, checkpoint inhibitors help T …

Most of the patients with lung cancer are diagnosed at advanced stage, and they often lose
the opportunity of surgical therapy, most of whom fail to reach good prognosis after …

Triple-negative breast cancer (TNBC) is a special subtype of breast cancer in which several
common diagnostic biomarkers are lost. Due to the loss of expression of receptors, treatment …

Objective: To evaluate the efficacy of dendritic cell-cytokine-induced killer cell (DC-CIK)-
based immunotherapy combined with chemotherapy in the treatment of intermediate to …

Objective To examine the efficacy and safety of a sequential combination of chemotherapy
and autologous cytokine-induced killer (CIK) cell treatment in triple-negative breast cancer …

Abstracts Objective Cytokine-induced killer cells (CIK) therapy is the most commonly used
cellular immunotherapy. The CIK plus radiotherapy was clinically used in a wide range of …

Background Cancer heterogeneity poses a serious challenge concerning the toxicity and
adverse effects of therapeutic inhibitors, especially when it comes to combinatorial therapies …

检查点抑制剂 (immune checkpoint inhibitors, ICIs) 治疗是目前最常用的免疫治疗方案,
已被批准用于黑色素瘤, 肾癌, 头颈癌, 膀胱癌等多种肿瘤的临床治疗, 在肺癌治疗中更是取得 …

The idea of utilizing the human immune system to eradicate tumors has been successfully
practiced for the past decades, as reported in multiple published studies. Among cancer …